Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of medicine, can solve the problems of patients' discomfort, slow onset of effect, and influence on curative effect
Active Publication Date: 2014-11-19
BEIZHEN SHANQING PHARMA
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
These medicaments that this area uses all are to treat vaginitis, and vaginitis is divided into many kinds: trichomonas vaginitis, bacterial vaginitis, mycotic vaginitis, mixed vaginitis etc., these inflammations again with mixed vaginitis Vaginitis is the most difficult to eradicate, and the recurrence rate is extremely high. The use effect of these dosage forms shows that Shuangzotai has a poor therapeutic effect on mixed vaginitis. According to the analysis of the feedback from the use, the main reason is that effervescent tablets need to absorb water It can disintegrate, and there is a burning sensation for patients with vaginal dryness; suppositories need to be melted by body temperature, and the onset of action is slow; and the disintegration or melting of suppositories and effervescent tablets has a short residence time, and the drugabsorption effect is poor, so it is not suitable for repeated attacks. The curative effect of vaginitis is not good; the ointment is an oily base, which affects the normal function of the skin and mucous membrane, and the contact surface with the mucous membrane is small, and the effective residence time in the vagina is short, thus affecting the curative effect
[0009] Many existing bizoate preparations are solid preparations or oil-based preparations, such as vaginal effervescent tablets, vaginal suppositories, etc. Vaginal effervescent tablets are prone to discomfort to patients due to their dry surface , and the suppository made with lipophilic matrix is easy to stain clothing and will also cause discomfort to patients, so it is urgently expected by those skilled in the art to make bisazole preparations such as ointment preparations with hydrophilic matrix for clinical use
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0084] Embodiment 1: preparation pharmaceutical composition of the present invention
[0089] (2), heat the purified water (60 grams) of 60% of the total weight of the prescription to 40°C-50°C, add chlorhexidine acetate to the above-mentioned purified water, stir fully, make it dissolve completely, become a clear solution, and keep The solution temperature is 40°C-50°C;
[0090] (3), metronidazole, clotrimazole and sodium carboxymethylcellulose in the step (1) are mixed in a mixer to obtain a uniform mixed powder;
[0091] (4), glycerin is slowly added in the solution of step (2), stirs while adding, mixes evenly, obtains clear solution;
[0114] Embodiment 2: preparation pharmaceutical composition of the present invention
[0115] formula:
[0116]
[0117] Preparation method: prepare according to the method of Example 1, the difference is that the pH value is adjusted to the specified value; the number of the obtained composition can be recorded as Ex2.
Embodiment 3
[0118] Embodiment 3: preparation pharmaceutical composition of the present invention
[0119] formula:
[0120]
[0121] Preparation method: prepare according to the method of Example 1, the difference is that the pH value is adjusted to the specified value; the number of the obtained composition can be recorded as Ex3.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a pharmaceutical composition containing metronidazole and particularly relates to a pharmaceutical composition. The pharmaceutical composition contains metronidazole, clotrimazole, chlorhexidine acetate, sodiumcarboxymethyl starch, sodium carboxymethylcellulose, glycerine and water. The pharmaceutical composition disclosed by the invention has favorable pharmaceutical properties.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.